We deleted CAD in three human tumor cell lines of different tissue origin, HeLa (cervical carcinoma), MDA-MB-231 (breast carcinoma) and 1205Lu (metastatic melanoma) (Fig. S1A). This evidence concerns the gene CAD and breast carcinoma.